title: Corrigendum: CRISPR-Cas9 mediated efficient PD-1 disruption on human primary T cells from cancer patients.
authors.forename: Shu
authors.initials: S
authors.lastname: Su
authors.forename: Bian
authors.initials: B
authors.lastname: Hu
authors.forename: Jie
authors.initials: J
authors.lastname: Shao
authors.forename: Bin
authors.initials: B
authors.lastname: Shen
authors.forename: Juan
authors.initials: J
authors.lastname: Du
authors.forename: Yinan
authors.initials: Y
authors.lastname: Du
authors.forename: Jiankui
authors.initials: J
authors.lastname: Zhou
authors.forename: Lixia
authors.initials: L
authors.lastname: Yu
authors.forename: Lianru
authors.initials: L
authors.lastname: Zhang
authors.forename: Fangjun
authors.initials: F
authors.lastname: Chen
authors.forename: Huizi
authors.initials: H
authors.lastname: Sha
authors.forename: Lei
authors.initials: L
authors.lastname: Cheng
authors.forename: Fanyan
authors.initials: F
authors.lastname: Meng
authors.forename: Zhengyun
authors.initials: Z
authors.lastname: Zou
authors.forename: Xingxu
authors.initials: X
authors.lastname: Huang
authors.forename: Baorui
authors.initials: B
authors.lastname: Liu